Top Markets
#1 MowCat MowCat +49.06%
#2 Velvet Velvet +37.57%
#3 Derive Derive +19.79%
#4 Audiera Audiera +18.76%
#5 Quack AI Quack AI +18.38%
#6 Bermuda Shorts Bermuda Shorts +15.44%
#7 aPriori aPriori +14.44%
#8 Biconomy Biconomy +14.37%
#9 Cross Cross +12.38%
#10 MarsCoin MarsCoin +12.30%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Sandu Pharmaceuticals Limited Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited

SANDUPHQ
Rank in Stocks #35409
Sandu Pharmaceuticals Limited specializes in the production and distribution of... Sandu Pharmaceuticals Limited specializes in the production and distribution of traditional Ayurvedic remedies. The company's extensive product line features various well-known brands, including Berbenteron (available as both suspension and tablets), Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin, and Pentazyme. Founded on May 10, 1899, its corporate headquarters are located in Mumbai, India.
Share Price
$0.40788602
Last synced: 2026-08-14
Market Cap
$3.94M
Change (1 day)
1.90%
Change (1 year)
-26.05%
Country
IN
Trade Sandu Pharmaceuticals Limited (SANDUPHQ)

Category

Healthcare
Revenue for Sandu Pharmaceuticals Limited (SANDUPHQ)
Revenue in Aug 2026 TTM: 0
According to Sandu Pharmaceuticals Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sandu Pharmaceuticals Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US